FERMIANISH

CADILA HEALTHCARE

Long
FERMIANISH Updated   
NSE:CADILAHC   None
READY FOR NEXT SPRINT, SUBMITTED DATA OF TRIALS TO GOVERNMENT AND CROSSING RECENT HIGHEST CLOSING WITH VOLUMES. NEWS OF VACCINE APPROVAL IN NEXT WEEK MAY BE. TARGET IS UNCHARTED.
KEEP SUPPORT AT 630, FOR POSITIONAL VIEW.
Comment:
Stoploss Hit
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.